These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 33758361)

  • 21. Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients.
    Casula EP; Stampanoni Bassi M; Pellicciari MC; Ponzo V; Veniero D; Peppe A; Brusa L; Stanzione P; Caltagirone C; Stefani A; Koch G
    Parkinsonism Relat Disord; 2017 Jan; 34():31-37. PubMed ID: 27771287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-frequency oscillations in Parkinson's disease: spatial distribution and clinical relevance.
    Wang J; Hirschmann J; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
    Mov Disord; 2014 Sep; 29(10):1265-72. PubMed ID: 25041924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dorsolateral subthalamic neuronal activity enhanced by median nerve stimulation characterizes Parkinson's disease during deep brain stimulation with general anesthesia.
    Tsai ST; Chuang WY; Kuo CC; Chao PC; Chen TY; Hung HY; Chen SY
    J Neurosurg; 2015 Dec; 123(6):1394-400. PubMed ID: 26024004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinsonian Beta Dynamics during Rest and Movement in the Dorsal Pallidum and Subthalamic Nucleus.
    Eisinger RS; Cagle JN; Opri E; Alcantara J; Cernera S; Foote KD; Okun MS; Gunduz A
    J Neurosci; 2020 Apr; 40(14):2859-2867. PubMed ID: 32107277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors.
    Yu C; Cassar IR; Sambangi J; Grill WM
    J Neurosci; 2020 May; 40(22):4323-4334. PubMed ID: 32312888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct subthalamic coupling in the ON state describes motor performance in Parkinson's disease.
    Ozturk M; Abosch A; Francis D; Wu J; Jimenez-Shahed J; Ince NF
    Mov Disord; 2020 Jan; 35(1):91-100. PubMed ID: 31348550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep brain stimulation for Parkinson's disease modulates high-frequency evoked and spontaneous neural activity.
    Sinclair NC; McDermott HJ; Fallon JB; Perera T; Brown P; Bulluss KJ; Thevathasan W
    Neurobiol Dis; 2019 Oct; 130():104522. PubMed ID: 31276793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pallidal Deep-Brain Stimulation Disrupts Pallidal Beta Oscillations and Coherence with Primary Motor Cortex in Parkinson's Disease.
    Wang DD; de Hemptinne C; Miocinovic S; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    J Neurosci; 2018 May; 38(19):4556-4568. PubMed ID: 29661966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative theory of deep brain stimulation of the subthalamic nucleus for the suppression of pathological rhythms in Parkinson's disease.
    Müller EJ; Robinson PA
    PLoS Comput Biol; 2018 May; 14(5):e1006217. PubMed ID: 29813060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.
    López-Azcárate J; Tainta M; Rodríguez-Oroz MC; Valencia M; González R; Guridi J; Iriarte J; Obeso JA; Artieda J; Alegre M
    J Neurosci; 2010 May; 30(19):6667-77. PubMed ID: 20463229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dominant efficiency of nonregular patterns of subthalamic nucleus deep brain stimulation for Parkinson's disease and obsessive-compulsive disorder in a data-driven computational model.
    Karamintziou SD; Deligiannis NG; Piallat B; Polosan M; Chabardès S; David O; Stathis PG; Tagaris GA; Boviatsis EJ; Sakas DE; Polychronaki GE; Tsirogiannis GL; Nikita KS
    J Neural Eng; 2016 Feb; 13(1):016013. PubMed ID: 26695534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of beta and high-frequency oscillations within the subthalamic nucleus region.
    van Wijk BCM; Pogosyan A; Hariz MI; Akram H; Foltynie T; Limousin P; Horn A; Ewert S; Brown P; Litvak V
    Neuroimage Clin; 2017; 16():175-183. PubMed ID: 28794978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological recordings from electrodes implanted in the basal ganglia for deep brain stimulation in Parkinson's disease. the relevance of fast subthalamic rhythms.
    Foffani G; Ardolino G; Rampini P; Tamma F; Caputo E; Egidi M; Cerutti S; Barbieri S; Priori A
    Acta Neurochir Suppl; 2005; 93():97-9. PubMed ID: 15986736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of subthalamic neurons by contralateral subthalamic deep brain stimulation in Parkinson disease.
    Walker HC; Watts RL; Schrandt CJ; Huang H; Guthrie SL; Guthrie BL; Montgomery EB
    J Neurophysiol; 2011 Mar; 105(3):1112-21. PubMed ID: 21177996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep brain stimulation of the subthalamic nucleus affects resting EEG and visual evoked potentials in Parkinson's disease.
    Jech R; Růzicka E; Urgosík D; Serranová T; Volfová M; Nováková O; Roth J; Dusek P; Mecír P
    Clin Neurophysiol; 2006 May; 117(5):1017-28. PubMed ID: 16516544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease.
    Telkes I; Viswanathan A; Jimenez-Shahed J; Abosch A; Ozturk M; Gupte A; Jankovic J; Ince NF
    Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8567-E8576. PubMed ID: 30131429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.